[Possibilities, failures and prospects of studies on tumor markers in oncological clinics. 1. (lecture)].
Kushlinskiĭ
N E
NE
D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D053539:Keratin-19; D007633:Keratins; D008175:Lung Neoplasms / Q000175:diagnosis; D008297:Male; D009369:Neoplasms / Q000175:diagnosis*; D009376:Neoplasms, Hormone-Dependent / Q000175:diagnosis; D017430:Prostate-Specific Antigen / Q000032:analysis; D011471:Prostatic Neoplasms / Q000175:diagnosis; D019098:Telomerase / Q000032:analysis
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D053539:Keratin-19; C102012:antigen CYFRA21.1; D007633:Keratins; D019098:Telomerase; D017430:Prostate-Specific Antigen